Free Helpline
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
An in-depth look at Onfi (clobazam) for managing seizures in Lennox-Gastaut Syndrome (LGS), covering its uses, side effects, dosage, and safety information for Indian patients.
Seizures can be a frightening and disruptive part of life, especially for individuals with complex neurological conditions. When seizures become a persistent challenge, finding the right medication can feel like a monumental task. For those diagnosed with Lennox-Gastaut Syndrome (LGS), a severe form of epilepsy, Onfi (clobazam) has emerged as a significant treatment option. This article aims to provide a thorough understanding of Onfi, its role in managing LGS seizures, potential side effects, and what patients and their families need to know.
Lennox-Gastaut Syndrome (LGS) is a rare and challenging epilepsy syndrome that typically begins in early childhood. It's characterized by a combination of frequent, diverse seizure types, intellectual disability, and specific abnormalities on an electroencephalogram (EEG). The seizures in LGS can be particularly difficult to control, often requiring a multi-faceted treatment approach. Onfi, with its active ingredient clobazam, belongs to a class of drugs known as benzodiazepines. These medications work by enhancing the effect of a neurotransmitter called gamma-aminobutyric acid (GABA) in the brain. GABA acts as a natural brake on nerve cell activity, and by boosting its effects, clobazam helps to reduce the abnormal electrical activity that leads to seizures.
Onfi is specifically approved for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in adults and children aged 2 years and older. It is important to understand that Onfi is not a cure for LGS, but rather a tool to help manage and reduce the frequency and severity of seizures. It is typically used as an add-on therapy, meaning it is taken in conjunction with other anti-epileptic drugs (AEDs) that the patient is already using. The goal is to achieve better seizure control when other treatments alone haven't been fully effective.
As a benzodiazepine, Onfi (clobazam) acts on the central nervous system. It works by increasing the activity of GABA, a neurotransmitter that inhibits brain activity. By enhancing GABA's effects, Onfi helps to calm the overactive nerve cells in the brain that trigger seizures. This action helps to stabilize electrical activity and prevent the uncontrolled firing that leads to seizure episodes.
Onfi is available in two forms: tablets and a liquid suspension. Both are taken orally.
The dosage of Onfi is highly individualized and depends on several factors, including the patient's age, weight, response to the medication, and the severity of their LGS. Doctors will typically start with a low dose and gradually increase it to find the optimal balance between seizure control and minimizing side effects. For instance, a starting dose might be 5 mg taken once or twice daily, with adjustments made as needed. Dosages higher than 5 mg per day are usually divided into two doses to maintain more consistent levels of the medication in the body.
Like all medications, Onfi can cause side effects. While many are mild and manageable, some can be serious. It's vital for patients and caregivers to be aware of these potential effects.
Many people experience mild side effects that may resolve on their own over time. These can include:
If these mild side effects become bothersome or do not disappear, it is important to discuss them with your doctor or pharmacist.
While less common, serious side effects can occur. These require immediate medical attention:
Immediate Action for Serious Side Effects: If you or someone you know experiences any of these serious side effects, stop taking Onfi and call your doctor immediately. If you believe you are having a medical emergency, call 112 or your local emergency number. If you have thoughts of harming yourself or others, call 911 or your local emergency number. The National Suicide Prevention Lifeline is also available 24/7 at 800-273-8255.
Onfi carries several important safety warnings that patients and caregivers must heed.
The FDA has issued a boxed warning about the increased risk of suicidal thoughts and behaviors with anti-epileptic drugs, including Onfi. Patients taking Onfi should be closely monitored for any new or worsening depression, unusual changes in mood or behavior, or suicidal thoughts. Family members and caregivers should report any concerns to the doctor immediately.
Abruptly stopping Onfi can lead to withdrawal symptoms, which may include anxiety, insomnia, tremors, nausea, vomiting, and even seizures. If it's necessary to stop taking Onfi, the dose should be gradually reduced under the supervision of a healthcare professional.
Long-term use of benzodiazepines like Onfi can lead to tolerance (needing a higher dose for the same effect) and physical dependence. This is why it's prescribed under strict medical supervision and not typically for extended periods without careful consideration.
Onfi can interact with other medications. It's crucial to inform your doctor about all prescription drugs, over-the-counter medicines, vitamins, and herbal supplements you are taking. Particular caution is needed when Onfi is taken with:
Information regarding the safety of Onfi during pregnancy and breastfeeding is limited. If you are pregnant, planning to become pregnant, or breastfeeding, discuss the risks and benefits with your doctor. Neonatal withdrawal symptoms can occur if Onfi is taken during late pregnancy.
The diagnosis of Lennox-Gastaut Syndrome is typically made by a neurologist based on a combination of:
Once Onfi is prescribed, regular monitoring by a healthcare professional is essential. This includes assessing seizure control, checking for side effects, and potentially monitoring blood levels of the medication to ensure effectiveness and safety.
You should always consult your doctor if:
If you suspect you have taken too much Onfi, contact your doctor immediately. You can also call the American Association of Poison Control Centers at 800-222-1222. In case of severe symptoms, call 911 or go to the nearest emergency room.
Managing LGS is a journey that requires a strong support system. Onfi can be a valuable part of treatment, but it's one piece of a larger puzzle. Alongside medication, therapies such as ketogenic diets, vagus nerve stimulation, and potentially epilepsy surgery may be considered. Education for both the patient and their family is paramount. Understanding the condition, the medication, and how to respond to seizures empowers individuals and their loved ones. Support groups can also provide emotional and practical assistance, connecting families with others facing similar challenges.
Yes, Onfi can be taken with or without food. If you experience stomach upset, taking it with food may help.
The time it takes for Onfi to start working can vary. Some individuals may notice a reduction in seizures within a few weeks, while for others, it may take longer. Consistent use as prescribed by your doctor is key.
Onfi is a benzodiazepine and can lead to physical dependence and tolerance with prolonged use. It is not typically considered
Overall, early action and medically verified advice remain the safest approach.
Discover effective methods to remove and prevent stubborn blackheads on your nose. Learn about ingredients like salicylic acid, retinoids, and gentle cleansing routines suitable for Indian skin.
April 1, 2026
Learn effective ways to remove blackheads from your nose and prevent them with expert tips on cleansing, exfoliation, and skincare. Achieve clearer skin today!
April 1, 2026
Discover if pure aloe vera gel can effectively reduce the appearance of acne scars. Learn about its benefits, how to use it, and what results to expect.
April 1, 2026